52 Results

People

  1. Bertino
    Bertino
  2. Gorlick
    Gorlick
  3. Banerjee
    Banerjee
  4. De Angelis
    De Angelis
  5. Minsky
    Minsky
  6. Seidman
    Seidman
  7. Fong
    Fong
  8. Guillem
    Guillem
  9. Hochhauser
    Hochhauser
  10. Hudis
    Hudis

Groups

  1. Department of Medicine (21)
  2. Solid Tumor Oncology Division (17)
  3. Gastrointestinal Oncology Service (8)
  4. Pediatrics, Department of (7)
  5. Survivorship Research (7)
  6. Center for Pancreatic Cancer Research (6)
  7. GSK Faculty (6)
  8. Breast Medicine Service (5)
  9. Radiology, Department of (5)
  10. Tow Center for Developmental Oncology (TCDO) (5)
  1. "antineoplastic antimetabolite"
Formats
  1. Journal Article (47)
  2. Research Letter (2)
  3. Review (2)
  4. Editorial (1)
Groups
  1. Department of Medicine (21)
  2. Solid Tumor Oncology Division (17)
  3. Gastrointestinal Oncology Service (8)
  4. Pediatrics, Department of (7)
  5. Survivorship Research (7)
  6. Center for Pancreatic Cancer Research (6)

More Groups

People
  1. Joseph Bertino (6)
  2. Richard Gorlick (4)
  3. Andrew Seidman (3)
  4. Bruce Minsky (3)
  5. Debabrata Banerjee (3)
  6. Lisa De Angelis (3)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (1)
  4. 2020 (3)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Oncology (Norwalk) (4)
  3. International Journal of Cancer (2)
  4. Journal of the National Comprehensive Cancer Network (2)
  5. Oncology Research (2)
  6. Acta Biochimica Polonica (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Springer (6)
  3. C M P Medica LLC * The Oncology Group (4)
  4. Lippincott Williams & Wilkins (4)
  5. Nature Publishing Group (4)
  6. John Wiley & Sons (3)

More Publishers

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes: Hypogammaglobulinemia after rituximab in children
    Journal Article

    HoĢˆppener, S. P. C.; Veldkamp, S. R.; de Groot, M. C. H.; Haitjema, S.; Drylewicz, J.; Boelens, J. J.; Lindemans, C. A.; van Montfrans, J.; van Royen-Kerkhof, A.; Jansen, M. H. A.
    Clinical Immunology Communications (2025)

    Fulltext@MSK | Save
  • New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid
    Review

    Heldrup, J.; Bleyer, A.; Ramsey, L.; Schaff, L.; Bernhardt, B.; Schwartz, S.; Chatelut, E.; Hwang, M.; Ten, C.; Guscott, M.; more...
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • Low-dose planned glucarpidase allows safe outpatient high-dose methotrexate treatment for CNS lymphoma
    Journal Article

    Schaff, L. R.; Carlow, D.; Schofield, R.; Wongchai, V.; Madzsar, J.; Hyde, A.; Reiner, A. S.; Panageas, K. S.; DeAngelis, L. M.; Mellinghoff, I. K.; more...
    JCO Oncology Practice (2024)

    Fulltext@MSK | Save
  • Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
    Research Letter

    Connor, M. P.; Prathapa, N.; Frey, N. V.; Gill, S. I.; Hexner, E. O.; Bruno, X. J.; Lai, C. E.; Loren, A. W.; Luger, S. M.; Matthews, A. H.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • APOBEC3 upregulation drives gemcitabine resistance
    Editorial

    Maciejowski, J.; Mohamed, T.
    Nature Cancer (2024)

    Fulltext@MSK | Save
  • Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
    Research Letter

    Zeidan, A. M.; Bewersdorf, J. P.; Hasle, V.; Shallis, R. M.; Thompson, E.; de Menezes, D. L.; Rose, S.; Boss, I.; Halene, S.; Haferlach, T.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: Report from the Childhood Cancer Survivor Study
    Journal Article

    de Blank, P.; Li, N.; Fisher, M. J.; Ullrich, N. J.; Bhatia, S.; Yasui, Y.; Sklar, C. A.; Leisenring, W.; Howell, R.; Oeffinger, K.; more...
    Genetics in Medicine (2020)

    Fulltext@MSK | Save
  • Radiotherapy and late effects
    Review

    Palmer, J. D.; Hall, M. D.; Mahajan, A.; Paulino, A. C.; Wolden, S.; Constine, L. S.
    Pediatric Clinics of North America (2020)

    Fulltext@MSK | Save
  • Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: A retrospective cohort analysis from the Childhood Cancer Survivor Study
    Journal Article

    Suh, E.; Stratton, K. L.; Leisenring, W. M.; Nathan, P. C.; Ford, J. S.; Freyer, D. R.; McNeer, J. L.; Stock, W.; Stovall, M.; Krull, K. R.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukemia: North American Intergroup Study SWOG S1117
    Journal Article

    Sekeres, M. A.; Othus, M.; List, A. F.; Odenike, O.; Stone, R. M.; Gore, S. D.; Litzow, M. R.; Buckstein, R.; Fang, M.; Roulston, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save